Science 37 Reports Quarterly Financial Results for the Period Ended September 30, 2021
15 nov. 2021 07h00 HE
|
Science 37, Inc.
LOS ANGELES, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”) the Operating System for today’s more agile clinical trials, today reported its financial...
Science 37 to Report Third Quarter 2021 Financial Results on November 15, 2021
01 nov. 2021 08h00 HE
|
Science 37, Inc.
LOS ANGELES, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Operating System for today’s more agile clinical trials, today announced it will report third quarter...
Science 37® and CMIC Announce Partnership to Advance Decentralized Clinical Trials in Japan/APAC and Speed Drug Development
27 oct. 2021 08h00 HE
|
Science 37, Inc.
LOS ANGELES and TOKYO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Science 37, the Operating System for today’s more agile clinical trials, and CMIC HOLDINGS Co., Ltd. (“CMIC”), the largest CRO in Japan today...
Science 37® and 3H Medi Solution Collaborate to Enable Decentralized Clinical Trials in Japan and Accelerate Patient Enrollment
27 oct. 2021 07h55 HE
|
Science 37, Inc.
LOS ANGELES and TOKYO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Science 37, the Operating System for today’s more agile clinical trials and 3H Medi Solution Inc., a clinical trials solution leader in Japan...
Industry-veteran Elisa Cascade Joins Science 37 as Chief Product Officer; Chris Ceppi appointed Chief Technology Officer
13 oct. 2021 07h55 HE
|
Science 37, Inc.
LOS ANGELES, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Science 37, the Operating System for today’s more agile clinical trials, announced Elisa Cascade has joined Science 37 and its senior executive team as...
Emily Rollins Appointed to Science 37® Board of Directors
12 oct. 2021 07h55 HE
|
Science 37, Inc.
With this important addition to its Board of Directors, Science 37 further advances its mission to accelerate clinical trials by enabling universal access to patients and providers. LOS ANGELES, Oct....
Science 37, the Operating System for Agile Clinical Trials, Closes Business Combination with LifeSci Acquisition II Corp. and Will Begin Trading on Nasdaq as SNCE
07 oct. 2021 08h00 HE
|
Science 37, Inc.
Science 37 to debut on Nasdaq as a publicly traded company under ticker symbol “SNCE”Business combination will provide Science 37 with approximately $235 million in cash proceeds to support continued...